Agilon Health (NYSE:AGL) Reaches New 52-Week High – What’s Next?

Agilon Health, Inc. (NYSE:AGL) hit a new 52-week high on Wednesday . The company traded as high as $126.00 and last traded at $124.9840, with a volume of 210302 shares changing hands. The stock had previously closed at $122.61.

Analyst Ratings Changes

Several equities analysts have recently issued reports on AGL shares. Deutsche Bank Aktiengesellschaft upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $33.00 to $49.00 in a report on Thursday, May 7th. TD Cowen reaffirmed a “hold” rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Benchmark reaffirmed a “buy” rating and issued a $95.00 target price (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $141.00 price target (up from $72.00) on shares of Agilon Health in a report on Monday. Five research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $64.00.

Agilon Health Trading Up 2.3%

The stock has a 50 day simple moving average of $96.23 and a 200-day simple moving average of $45.49. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $2.09 billion, a P/E ratio of -5.83 and a beta of 2.98.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. On average, equities research analysts forecast that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. North Peak Capital Management LLC raised its stake in shares of Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after buying an additional 3,715,460 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of Agilon Health by 196.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the period. AQR Capital Management LLC increased its holdings in Agilon Health by 1,346.6% in the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after acquiring an additional 9,505,837 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Agilon Health by 30.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock worth $5,523,000 after purchasing an additional 1,893,434 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Agilon Health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock worth $4,944,000 after purchasing an additional 35,054 shares in the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.